Wednesday, June 7, 2017

CORRECTED-UPDATE 3-AbbVie's rheumatoid arthritis drug succeeds in trial

* Upadacitinib, a JAK inhibitor, more effective than a placebo

by reutersCOMPANYNEWS via Endless Supplies .Biz - News
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)